http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100720045-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dd7c27b9ec61781656e6f039702fd568 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-353 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-66 |
| filingDate | 2006-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2007-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eec90cfe6c98d15b0df154b5f968533c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4e7c460a9ecb41256e397a6610b4da4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36e13919481b266538e12ba89f31c4f2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6aa48afe0fe205ba239bc4d3e237f5f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fada36aaa19a428337fe698fa84df98 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bd04d5619448f27700183d1e5eb69bd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ec1dfc9ebd25da4ec9cf2187493eb2c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_452f975653c9d9c9219b159d533b2429 |
| publicationDate | 2007-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100720045-B1 |
| titleOfInvention | Novel chromonone oxime carbonylguanidine derivatives, pharmaceutically acceptable salts thereof, preparation methods thereof, and pharmaceutical compositions for the prevention and treatment of ischemic heart disease containing the same as active ingredients |
| abstract | The present invention provides a novel chromonone oxime carbonylguanidine derivative represented by the following formula (1) or a pharmaceutically acceptable salt thereof, a method for preparing the same, and prevention and treatment of ischemic heart disease containing the same as an active ingredient, or surgery or drug It relates to a pharmaceutical composition for use in cardioprotection during therapy procedures.n n n The novel chromonone oxime carbonylguanidine derivatives of the present invention may be used for the prevention and treatment of ischemic heart disease including myocardial infarction, heart failure, angina pectoris, or surgery therapy including coronary artery bypass surgery, coronary percutaneous plastic surgery, or pharmacotherapy using thrombolytic agents. It can be usefully used as a cardioprotective agent during reperfusion therapy.n n n <Formula 1>n n n n n n n n Chromone oxime carbonylguanidine, NHE-1, ischemic heart disease, cardioprotectant |
| priorityDate | 2006-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.